Nuzenio

Tempus

Tempus news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 18 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 12:48:30 GMTWhy Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network - simplywall.st
Sat, 08 Aug 2026 12:37:00 GMTTempus AI Stock Drops As $1.5B Personalis Deal Ups The MRD Stakes - StocksToTrade
Sat, 08 Aug 2026 09:15:41 GMTTempus AI Expands Cancer Platform With Launch of ArteraAI Prostate Test For Metastatic Patients - Stocktwits
Fri, 07 Aug 2026 18:21:02 GMTWhy Is Tempus AI Stock Surging on Friday? - Benzinga
Fri, 07 Aug 2026 11:00:39 GMTCellCarta adds Tempus to companion diagnostic commercialisation network - Manufacturing Chemist
Thu, 06 Aug 2026 13:15:00 GMTCellCarta Adds Tempus to CDx Commercialization Lab Network - PR Newswire

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tempus.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

18 distinct publisher/source names are currently connected to this entity page.